New Zealand directs heavy criticism at ANZTPA draft as "not addressing key issues"
This article was originally published in Clinica
Executive Summary
New Zealand industry's dissenting voice has been added to that of Australia's with both finding themselves dismayed over the first draft of the joint therapeutics regulatory authority (ANZTPA - see Clinica No 1215, p 12).